Haemonetics Corporation (HAE)

Net profit margin

		Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021
Net income	US$ in thousands	167,679	117,558	115,401	43,375	79,469
Revenue	US$ in thousands	1,360,820	1,309,060	1,168,660	993,196	870,463
Net profit margin		12.32%	8.98%	9.87%	4.37%	9.13%

March 31, 2025 calculation

Net profit margin = Net income ÷ Revenue
= $167,679K ÷ $1,360,820K
= 12.32%

The net profit margin of Haemonetics Corporation has exhibited fluctuations over the past five years. In March 2021, the net profit margin stood at 9.13%, indicating that the company retained approximately 9.13% of its total revenue as profit after all expenses were deducted. This margin decreased to 4.37% by March 2022, signaling a significant drop in profitability. However, there was a notable recovery in March 2023, with the net profit margin increasing to 9.87%. The margin then slightly declined to 8.98% by March 2024.

The most recent data from March 2025 shows a substantial improvement in profitability, with the net profit margin reaching 12.32%. This suggests that Haemonetics Corporation has efficiently managed its costs and expenses relative to its revenue, resulting in higher profitability. Overall, the fluctuation in the net profit margin over the years indicates that the company has experienced varying degrees of efficiency in generating profits from its operations.